Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Coarse, as well as fine, particulate matter increases asthma risk in children

Study finds that exposure to coarse particulate matter is significantly associated with an increased relative rate of asthma diagnosis, independent of exposure to fine particulate matter.

Evidence suggests that short- and long-term exposure to fine particulate matter (PM2.5) is associated with asthma development and morbidity; however, little is known about the long-term effects of coarse particulate matter (PM10–2.5).

In a study in the American Journal of Respiratory & Critical Care Medicine (online, 15 December 2017), researchers studied data on asthma prevalence and morbidity from 7,810,025 children aged 5–20 years over a two-year period and compared it with their estimated average exposure to fine and coarse PM over the same time period[1].

They found that each unit increase in exposure to PM10–2.5 was significantly associated with an increased relative rate of asthma diagnosis, independent of PM2.5 exposure. It was also associated with an increased risk of admission to hospital and emergency department visits, although the magnitude of these effects was greater for PM2.5 exposure.

The researchers concluded that coarse particulate matter levels should be directly monitored and that stricter environmental limits could be put into place.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204329

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Young child with inhaler

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.